Trademark: 79193347
Status Date
Friday, December 29, 2023
Registration Number
5220413
Registration Date
Tuesday, June 13, 2017
Filing Date
Tuesday, July 19, 2016
Published for Opposition
Tuesday, March 28, 2017
Cancellation Date
Friday, December 29, 2023
5 Pharmaceutical products, namely, pharmaceutical preparations containing sumatriptan for treating migraine and histamine cephalgia only
Dec 29, 2023
Cancelled Section 71
Jun 13, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Oct 28, 2017
Final Decision Transaction Processed By Ib
Sep 21, 2017
Final Disposition Notice Sent To Ib
Sep 21, 2017
Final Disposition Processed
Sep 21, 2017
Limitation From The Ib Examined, No Action Is Needed
Sep 13, 2017
Final Disposition Notice Created, To Be Sent To Ib
Aug 17, 2017
Limitation Of Goods Received From Ib
Jun 13, 2017
Registered-Principal Register
Mar 28, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2017
Published For Opposition
Mar 25, 2017
Notification Processed By Ib
Mar 8, 2017
Notification Of Possible Opposition Sent To Ib
Mar 8, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 8, 2017
Notification Of Notice Of Publication E-Mailed
Feb 22, 2017
Law Office Publication Review Completed
Feb 10, 2017
Approved For Pub - Principal Register
Feb 10, 2017
Teas/Email Correspondence Entered
Feb 10, 2017
Correspondence Received In Law Office
Feb 8, 2017
Assigned To Lie
Jan 24, 2017
Teas Response To Office Action Received
Nov 18, 2016
Refusal Processed By Ib
Nov 1, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Nov 1, 2016
Refusal Processed By Mpu
Nov 1, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Oct 31, 2016
Non-Final Action Written
Oct 29, 2016
Assigned To Examiner
Oct 18, 2016
Application Filing Receipt Mailed
Oct 14, 2016
New Application Office Supplied Data Entered
Oct 13, 2016
Limitation From Original Application Entered
Oct 6, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
